Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gebel

Showing results (231-240 of 294) with videos related to

Pageof 30
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
Human Immunology|August 7, 2018
(F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatchHarold C Sullivan, Christina L Dean, Robert S Liwski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 17, 2022
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantationLoren Gragert, Matthew Kadatz, James Alcorn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2018
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studiesR A Bray, H M Gebel, R Townsend, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individualsM Clerici, D R Lucey, R A Zajac, et al.
Transplantation|December 4, 2020
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 ProteinsRobert A Bray, Jar-How Lee, Peter Brescia, et al.
Histopathology|January 1, 1996
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel diseaseS C Bischoff, J Wedemeyer, A Herrmann, et al.
Transfusion|September 29, 2018
Stability of anti-A blood group titers among blood group B renal transplant candidatesReuben P Jacob, Christina L Dean, Scott M Krummey, et al.
Gut|June 1, 1997
Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergyS C Bischoff, J Mayer, J Wedemeyer, et al.
Journal of the American College of Cardiology|September 3, 2013
Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipientsAlanna A Morris, Robert T Cole, Emir Veledar, et al.
Pageof 30

Showing results (231-240 of 294) with videos related to

Sort By:
Pageof 30
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
Human Immunology|August 7, 2018
(F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatchHarold C Sullivan, Christina L Dean, Robert S Liwski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 17, 2022
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantationLoren Gragert, Matthew Kadatz, James Alcorn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2018
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studiesR A Bray, H M Gebel, R Townsend, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individualsM Clerici, D R Lucey, R A Zajac, et al.
Transplantation|December 4, 2020
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 ProteinsRobert A Bray, Jar-How Lee, Peter Brescia, et al.
Histopathology|January 1, 1996
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel diseaseS C Bischoff, J Wedemeyer, A Herrmann, et al.
Transfusion|September 29, 2018
Stability of anti-A blood group titers among blood group B renal transplant candidatesReuben P Jacob, Christina L Dean, Scott M Krummey, et al.
Gut|June 1, 1997
Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergyS C Bischoff, J Mayer, J Wedemeyer, et al.
Journal of the American College of Cardiology|September 3, 2013
Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipientsAlanna A Morris, Robert T Cole, Emir Veledar, et al.
Pageof 30